Svelte Medical Systems, Inc. (Svelte) is a privately held company focused on delivering novel products in the $5 billion coronary stent market. Svelte was founded in 2007 by Robert Fischell, ScD, David Fischell, PhD and Tim Fischell, MD with a mission to address key clinical issues in the stent market by improving stent deliverability, reducing cost and dramatically improving the safety of the device compared to currently market products.
Svelte has developed the lowest profile and most deliverable balloon expandable stent in the market, along with technology to create a non-thrombogenic, non-inflammatory Drug Eluting Stent (DES).
Current Team (7)Update
President & CEO
European Business Director
Chairman Of The Board and Chief Technical Officer
Vice President, Quality Assurance
Chief Operating Officer
Vice President of Sales and Marketing
Funding Rounds (8) - $5MUpdate
Board Members and Advisors (6)Update
NY VC in early/late stage in performance
Established in 1997, CNF is the CEI affiliate that actively invests in venture capital and...
Lowering health care cost
Apjohn Ventures Fund is a new venture capital firm based in Kalamazoo, Michigan established to...
Av. Juscelino Kubitschek
no 28, cj. 32 / Itaim, Bibi
Rue des Colonies - Koloniënstraat, 11 Room 1.11
675 Central Avenue
New Providence, NJ 07974